1-248361920-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004696.2(OR2T4):c.256C>A(p.Leu86Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000447 in 1,613,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004696.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2T4 | NM_001004696.2 | c.256C>A | p.Leu86Ile | missense_variant | 1/1 | ENST00000366473.4 | NP_001004696.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2T4 | ENST00000366473.4 | c.256C>A | p.Leu86Ile | missense_variant | 1/1 | NM_001004696.2 | ENSP00000355429 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000251 AC: 63AN: 251306Hom.: 0 AF XY: 0.000250 AC XY: 34AN XY: 135814
GnomAD4 exome AF: 0.000463 AC: 677AN: 1461850Hom.: 0 Cov.: 81 AF XY: 0.000430 AC XY: 313AN XY: 727234
GnomAD4 genome AF: 0.000289 AC: 44AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2022 | The c.340C>A (p.L114I) alteration is located in exon 1 (coding exon 1) of the OR2T4 gene. This alteration results from a C to A substitution at nucleotide position 340, causing the leucine (L) at amino acid position 114 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at